Patients with genetic Pcsk1 deficiency experience obesity due to decreased proinsulin processing30, and a recently FDA-approved medication named setmelanotide is used as treatment for these patients38. Here, PCSK1 is linked to obesity due to melanocortin 4 receptor deficiency.